CLINICAL_TRIALS
trial_result
· 2021-02-08
Clinical Trial Update: Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients [Phase 3]
Summary
Long-term Phase 3 safety study of tanezumab in osteoarthritis was terminated, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-02-08